Evaluation of CA 19-9 levels in ovarian dermoid cysts

Basit Öğe Kaydı
dc.authorscopusid41862830000
dc.authorscopusid6506061779
dc.authorscopusid39760902600
dc.authorscopusid43261610000
dc.authorscopusid43262210900
dc.authorscopusid41861073000
dc.authorscopusid6504310163
dc.contributor.authorYüksel, Mehmet Aytaç
dc.contributor.authorAbalı, Remzi
dc.contributor.authorAras, Özlem
dc.contributor.authorTemel, İlkbal
dc.contributor.authorÜnal, Fehmi
dc.contributor.authorBoran, Ahmet Birtan
dc.contributor.authorPurisa, Sevim
dc.date.accessioned2022-05-11T14:35:50Z
dc.date.available2022-05-11T14:35:50Z
dc.date.issued2011
dc.departmentFakülteler, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Kadın Hastalıkları ve Doğum Ana Bilim Dalı
dc.description.abstractObjective: We aimed to evaluate the CA 19-9 levels in ovarian dermoid cysts. Material and Methods: Tumor markers and clinicopathologic features of 114 patients, treated between 2006-2010 in Department of Obstetrics and Gynecology, Istanbul Education and Research Hospital were evaluated retrospectively. All patients pathology reports revealed mature cystic teratoma. Patients evaluated according to the CA 19-9 levels (group1: normal, group2: high). Age, tumors size, bilaterality and CA19-9 levels were studied. Results: Mean age of the patients was 40.7 ± 12.3 (20-75). Nine patients (%12.5) were at postmenopausal ages. Tumor diameters were between 2-25 cm. Mean serum CA 19-9 level was 39.2 ± 76.8 U/mL, mean serum CA 125 level was 23.8 ± 29.1 U/ml, mean serum AFP level was 1.8 ± 1.5 ng/mL, mean serum CEA level was 1.7 ± 1.5 ng/mL and mean serum CA 15-3 was 15.3 ± 6.7 U/mL. CA 19-9 levels were the highest marker among patients (%19.4). Differences in mean age, tumor diameters and tumor marker levels excluded CA 19-9, were not statistically significant between two groups. Conclusion: Ca19-9 is the most frequent tumor marker detected high in mature cystic teratoma patients. Yet it is not sufficient alone for diagnosis. Tumor size and bilaterality is not correlated to the tumor marker levels. Copyright © 2011 by Türkiye Klinikleri.
dc.identifier.endpage194
dc.identifier.issn1300-0306
dc.identifier.issue3en_US
dc.identifier.scopus2-s2.0-79959685945
dc.identifier.scopusqualityN/A
dc.identifier.startpage190
dc.identifier.urihttps://hdl.handle.net/20.500.11776/8249
dc.identifier.volume21
dc.indekslendigikaynakScopus
dc.institutionauthorAbalı, Remzi
dc.language.isotr
dc.relation.ispartofTurkiye Klinikleri Jinekoloji Obstetrik
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectBiological
dc.subjectDermoid cyst
dc.subjectOvarian cysts
dc.subjectTumor markers
dc.subjectCA 19-9 antigen
dc.subjectadult
dc.subjectage
dc.subjectaged
dc.subjectarticle
dc.subjectdisease marker
dc.subjectfemale
dc.subjecthuman
dc.subjectmajor clinical study
dc.subjectovary teratoma
dc.subjectpostmenopause
dc.subjectprotein blood level
dc.subjecttumor volume
dc.titleEvaluation of CA 19-9 levels in ovarian dermoid cysts
dc.title.alternativeOvaryan dermoid kistlerde CA 19-9 seviyesinin de?erlendirilmesi]
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
8246.pdf
Boyut:
141.51 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
Tıp Fakültesi Koleksiyonu